Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
21.98
+1.22 (5.88%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Alto Neuroscience Market Cap
Alto Neuroscience has a market cap or net worth of $680.35 million as of March 9, 2026. Its market cap has increased by 708.53% in one year.
Market Cap
680.35M
Enterprise Value
547.90M
1-Year Change
708.53%
Ranking
Category
Stock Price
$21.98
Market Cap Chart
Since February 2, 2024, Alto Neuroscience's market cap has increased from $528.69M to $680.35M, an increase of 28.69%. That is a compound annual growth rate of 12.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 644.94M | 16.63% |
| Dec 31, 2025 | 552.98M | 384.71% |
| Dec 31, 2024 | 114.08M | -78.42% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gyre Therapeutics | 700.76M |
| ProKidney | 691.92M |
| Theravance Biopharma | 687.62M |
| Tectonic Therapeutic | 673.52M |
| MiMedx Group | 668.55M |
| Replimune Group | 666.36M |
| AgomAb Therapeutics NV | 663.79M |
| Zura Bio | 661.28M |